APA (7th ed.) Citation

MC, Y., YC, S., YL, H., ES, L., YS, L., EM, T., . . . PL, K. (2026). [Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer. Oncology reports, 55(2), . https://doi.org/10.3892/or.2025.9041

Chicago Style (17th ed.) Citation

MC, Yen, Shih YC, Hsu YL, Lin ES, Lin YS, Tsai EM, Ho YW, Hou MF, and Kuo PL. "[Corrigendum] Isolinderalactone Enhances the Inhibition of SOCS3 on STAT3 Activity by Decreasing MiR‑30c in Breast Cancer." Oncology Reports 55, no. 2 (2026). https://doi.org/10.3892/or.2025.9041.

MLA (9th ed.) Citation

MC, Yen, et al. "[Corrigendum] Isolinderalactone Enhances the Inhibition of SOCS3 on STAT3 Activity by Decreasing MiR‑30c in Breast Cancer." Oncology Reports, vol. 55, no. 2, 2026, https://doi.org/10.3892/or.2025.9041.